Chemistry researchers’ start-up takes aim at triple-negative breast cancer – without chemo side effects
Chemistry & Biochemistry’s Dr. Xiaohua Peng was featured in In Focus discussing her new start-up SynXT Therapeutics. SynXT Therapeutics (founded by Dr. Peng and former UWM graduate student Dr. Taufeeque Ali) are developing a new type of cancer therapy. This …